Analystreport

TG Therapeutics Inc (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $25.00 price target on the stock.

TG Therapeutics, Inc.  (TGTX) 
Last tg therapeutics, inc. earnings: 11/12 07:34 am Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com